Trial Details
COMPLETEDBasic Information
| Clinical ID | c1394 |
|---|---|
| Identifier | NCT01336465 |
| Trial Title | Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: placebo|DRUG: rhuMAb Beta7 |
Participant Information
| Sponsor | Genentech, Inc. |
|---|---|
| City | San Diego |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-09-11 |
|---|---|
| Primary Completion Date | 2025-09-12 |
| Completion Date | 2025-06-13 |